Carbamazepine

Indications & formulation #

Epilepsy label used for safety context; bipolar prescribing requires a separate indication-specific source. This reference covers the selected formulation; other indications and products need their own evidence.

Dose reference #

Adult educational reference · Oral chewable tablet · United States. The clinician selects treatment after assessment; this page does not calculate or change a prescription.

No bipolar regimen is inferred from this epilepsy formulation. Use the bipolar handbook and exact locally selected product before prescribing.

Contraindications & important cautions #

Avoid prior bone-marrow depression and MAOI coadministration. Serious skin reactions, blood dyscrasias, hepatic injury and hyponatraemia require assessment.

Selected important cautions; consult the full product information for all contraindications and warnings.

Adverse effects #

Dizziness, ataxia, hyponatraemia, blood/liver effects and serious skin reactions require review.

Interactions #

Broad enzyme induction can reduce exposure to other medicines, including hormonal contraception; inhibitors may raise carbamazepine exposure.

Monitoring #

Review blood count, liver function, sodium, interactions and ancestry-related testing where required by the selected label/local guidance.

Special populations #

Assess ancestry-related HLA testing requirements, liver function, CBC and sodium. Enzyme induction affects contraceptives and many psychotropics.

Adult scope. Pregnancy, breastfeeding and pediatric use require the exact product’s population-specific guidance and individual assessment.

Discontinuation, restarting & counseling #

Avoid abrupt withdrawal, particularly with seizure comorbidity; account for changing enzyme induction during switches.

Brands & products #

Reference coverage #

Structured summary of selected adult uses, not an exhaustive monograph. Indian product authorization and local prescribing requirements have not been reconciled.